November 26, 2025 · Form 4 insider transaction
BROSHY ERAN bought 14,000 shares of Theravance Biopharma, Inc. at $10.15 per share, a transaction worth $142.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
This Share Option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date).; Reflects solely exercisable, vested Share Options following reported transaction.